Large vessel giant cell arteritis
- PMID: 38574745
- DOI: 10.1016/S2665-9913(23)00300-4
Large vessel giant cell arteritis
Abstract
Giant cell arteritis is the principal form of systemic vasculitis affecting people over 50. Large-vessel involvement, termed large vessel giant cell arteritis, mainly affects the aorta and its branches, often occurring alongside cranial giant cell arteritis, but large vessel giant cell arteritis without cranial giant cell arteritis can also occur. Patients mostly present with constitutional symptoms, with localising large vessel giant cell arteritis symptoms present in a minority of patients only. Large vessel giant cell arteritis is usually overlooked until clinicians seek to exclude it with imaging by ultrasonography, magnetic resonance angiography (MRA), computed tomography angiography (CTA), or [18F]fluorodeoxyglucose-PET-CT. Although the role of imaging in treatment monitoring remains uncertain, imaging by MRA or CTA is crucial for identifying aortic aneurysm formation during patient follow up. In this Series paper, we define the large vessel subset of giant cell arteritis and summarise its clinical challenges. Furthermore, we identify areas for future research regarding the management of large vessel giant cell arteritis.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests KSMvdG reports a grant from FOREUM Foundation for Research in Rheumatology, speaker fees from Roche, and research support from AbbVie, all outside the submitted work and paid to the University Medical Center Groningen (UMCG). TAB reports research grants from Deutsche Forschungsgemeinschaft and Siemens Healthineers paid to his institution and personal consulting fees and honoraria for lectures from Bracco, BTR, Guerbet, Siemens Healthineers, Novartis, and Roche. RHJAS reports independent research grants from Siemens Healthineers and Pfizer. EB, as an employee of the UMCG, received grants from the Dutch Arthritis Society and the EU, European Federation of Pharmaceutical Industries and Associations, and Innovative Medicines Initiative 2 Joint Undertaking Immune-Image (grant no 831514), which were paid to the UMCG. All other authors declare no competing interests.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
